髓磷脂蛋白零样蛋白1对膀胱癌细胞增殖、迁移和侵袭的影响

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (2280 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effects of myelin protein zero like 1 (MPZL1) on proliferation, migration and invasion of bladder cancer T24 cells. Methods The expression of MPZL1 in bladder cancer T24 cells was knocked down by siRNA transfection to form an experimental model of bladder cancer cells that inhibited the expression of MPZL1. The cells were divided into si-NC group and si-MPZL1 group. The expression of MPZL1 gene in bladder cancer patients in TCGA database was analyzed online through ualcan database. The changes of cell proliferation were detected by CCK-8 assay and plate cloning assay, and the changes of cell migration and invasion were detected by scratch assay and Transwell assay. Results The MPZL1 gene was highly expressed in patients with bladder cancer and the expression level showed an increasing trend with the progress of clinical stage. The high expression of MPZL1 gene was significantly correlated with the shortened survival time of bladder cancer. Inhibition of MPZL1 expression could effectively inhibit the proliferation, migration and invasion of bladder cancer T24 cells. Conclusions Knocking down the expression of MPZL1 in bladder cancer T24 cells can inhibit the proliferation, migration and invasion of bladder cancer cells.

Key words： bladder cancer myelin protein zero like 1 proliferation migration invasion

Received: 06 January 2024

ZTFLH:

R737.14

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIA Lianjie
	FU Wenqiang
	LIU Yifei
	ZHANG Xiaolei
	WANG Baocun
	LI Yuzhu

Cite this article:

XIA Lianjie,FU Wenqiang,LIU Yifei等. Effects of MPZL1 on proliferation, migration and invasion of bladder cancer cells[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(5): 421-424.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2024/V35/I5/421

[1]	Antoni S, Ferlay J, Soerjomataram I, et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends[J].Eur Urol,2017,71(1):96-108.
[1]	Antoni S, Ferlay J, Soerjomataram I, et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends[J].Eur Urol,2017,71(1):96-108.
[2]	Zhao R, Zhao Z J. Identification of a variant form of PZR lacking immunoreceptor tyrosine-based inhibitory motifs [J]. Biochem Biophys Res Commun, 2003, 303(4): 1028-1033.
[2]	Zhao R, Zhao Z J. Identification of a variant form of PZR lacking immunoreceptor tyrosine-based inhibitory motifs [J]. Biochem Biophys Res Commun, 2003, 303(4): 1028-1033.
[3]	Zhao Z J, Zhao R. Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2 [J]. J Biol Chem,1998, 273(45): 29367-72.
[3]	Zhao Z J, Zhao R. Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2 [J]. J Biol Chem,1998, 273(45): 29367-72.
[4]	Jia D, Jing Y, Zhang Z, et al. Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma [J]. Cell Res, 2014, 24(2): 204-17.
[4]	Jia D, Jing Y, Zhang Z, et al. Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma [J]. Cell Res, 2014, 24(2): 204-17.
[5]	林凤娟,葛潇潇,吴峥,等.胃癌中MPZL1的表达及其对胃癌细胞增殖能力的影响[J].肿瘤防治研究, 2021, 48(7):7.
[5]	林凤娟,葛潇潇,吴峥,等.胃癌中MPZL1的表达及其对胃癌细胞增殖能力的影响[J].肿瘤防治研究, 2021, 48(7):7.
[6]	Hyuna S, Jacques F, Rebecca L S, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2021,71(3):209-249.
[6]	Hyuna S, Jacques F, Rebecca L S, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2021,71(3):209-249.
[7]	Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022 [J]. J Natl Cancer Cent,2024,4(1):213-218.
[7]	Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022 [J]. J Natl Cancer Cent,2024,4(1):213-218.
[8]	Lopez-Beltran A, Cookson M S, Guercio B J, et al.Advances in diagnosis and treatment of bladder cancer [J].BMJ,2024,12:e076743.
[8]	Lopez-Beltran A, Cookson M S, Guercio B J, et al.Advances in diagnosis and treatment of bladder cancer [J].BMJ,2024,12:e076743.
[9]	Ibrahim J, Sean O, Laura B, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors [J]. Eur Urol,2023,84(2):176-190.
[9]	Ibrahim J, Sean O, Laura B, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors [J]. Eur Urol,2023,84(2):176-190.
[10]	Lars D, Donna H, Jason E, et al.Bladder cancer [J]. Nat Rev Dis Primers,2023,26(1):58.
[10]	Lars D, Donna H, Jason E, et al.Bladder cancer [J]. Nat Rev Dis Primers,2023,26(1):58.
[11]	Zhao ZJ, Zhao R.Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2[J]. J Biol Chem,1998,273(45):29367-72.
[11]	Zhao ZJ, Zhao R.Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2[J]. J Biol Chem,1998,273(45):29367-72.
[12]	Zhao R, Zhao Z J. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs [J]. J Biol Chem, 2000, 275(8): 5453-5459.
[12]	Zhao R, Zhao Z J. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs [J]. J Biol Chem, 2000, 275(8): 5453-5459.
[13]	Yeh Y T, Dai H Y,Chien C Y. Amplification of MPZL1/PZR gene in hepatocellular carcinoma. Hepatobiliary Surg Nutr [J]. 2014,3(2): 87-90.
[13]	Yeh Y T, Dai H Y,Chien C Y. Amplification of MPZL1/PZR gene in hepatocellular carcinoma. Hepatobiliary Surg Nutr [J]. 2014,3(2): 87-90.
[14]	Alice B, François J M, Nicolas B. MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells [J]. Sci Rep,2017,14,7(1):11514.
[14]	Alice B, François J M, Nicolas B. MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells [J]. Sci Rep,2017,14,7(1):11514.
[15]	Feng J, Ouyang H, Wang J,et al. MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer [J]. Carcinogenesis,2022,43(10):919-929.
[15]	Feng J, Ouyang H, Wang J,et al. MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer [J]. Carcinogenesis,2022,43(10):919-929.